Form4insider filings, from the source

SEC Form 3 · accession 0001140361-16-062403

Bionik Laboratories Corp. · BNKL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Hermano Igo Krebs
Officer — Chief Science Officer
Period of report
Apr 21, 2016
Accepted (ET)
Apr 28, 2016 · 3:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001508381

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value 0.001 per shareF1holding———5,190,376D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)$0.95holding———Apr 21, 2016Mar 28, 2023Common Stock, par value $0.001 per share58,182—D
Employee Stock Option (Right to Buy)$0.95holding———Apr 21, 2016Mar 6, 2024Common Stock, par value $0.001 per share15,810—D
Employee Stock Option (Right to Buy)$1.05holding———Apr 21, 2016Mar 28, 2023Common Stock, par value $0.001 per share225,076—D
Employee Stock Option (Right to Buy)$1.05holding———Apr 21, 2016Mar 6, 2024Common Stock, par value $0.001 per share61,162—D
Employee Stock Option (Right to Buy)$0.95holding———Apr 21, 2016Mar 14, 2024Common Stock, par value $0.001 per share9,486—I
Employee Stock Option (Right to Buy)$1.05holding———Apr 21, 2016Mar 14, 2024Common Stock, par value $0.001 per share36,697—I
Employee Stock Option (RIght to Buy)$0.95holding———Apr 21, 2016Sep 30, 2024Common Stock, par value $0.001 per share9,486—I
Employee Stock Option (Right to Buy)$1.05holding———Apr 21, 2016Sep 30, 2024Common Stock, par value $0.001 per share36,697—I

Explanation of responses